Program in Cancer Research Outcomes Training (PCORT)

描述(由申请者提供)：我们请求继续为非常成功的Dana-Farber/哈佛癌症中心(DF/HCC)癌症结果研究培训计划(PCORT)提供资金。PCORT是一个独特的、以课程为基础的跨学科课程，致力于培训癌症结果和医疗保健服务研究方面的领导者，特别关注癌症的预防和控制。我们相信PCORT有足够的研究和培训机会来提供全面的研究培训体验，我们的成功--以及我们学员的成功--证明了继续提供资金的要求是合理的。 资金将允许每年继续招聘2000名新的医学博士和/或博士实习生和1名博士前实习生。由于所有学员在该计划中的学习时间至少为2年，因此我们将在任何时候保持6名学员参加该计划。我们将招聘具有不同研究经验和培训的个人，并将所有受训人员整合到一个高度协作的研究环境中。我们还将积极招募高素质的少数族裔和女性申请者参加该计划。 该计划包括三个部分：1)专业课程；2)积极参与其他教学体验；3)有指导的、多学科的癌症相关结果研究。专业课程包括每周一次的研讨会，既包括说教讲座，也包括由受训人员和教职员工进行的“正在进行的研究”演讲。具备相应资质的学员还将参加哈佛临床有效性项目(PCE)，这是布里格姆与妇女医院、马萨诸塞州总医院、哈佛医学院和哈佛公共卫生学院的联合项目。PCE是一个为期七周的强化课程，以15学分的课堂为基础，包括流行病学和生物统计学的必修课，以及各种选修课。我们鼓励学员参加或审核整个哈佛大学系统中与其培训水平相适应的其他课程。所有医学博士后研究员都要完成硕士学位(M.P.H.或M.Sc)在哈佛大学公共卫生学院。 受训者在PCORT导师的监督下，花了大部分时间参与有指导的癌症结果研究。个别项目由受训者、他/她的导师和PCORT项目主任商定制定，并由PCORT咨询委员会批准。所有项目都是多学科的、高度协作的。对团队科学的重视程度很高。受训者接触到广泛的癌症结果、研究方法和主题。 受训人员在整个培训过程中和完成培训后都要接受评估。在成功完成培训计划后，他们将为进行独立的、外部资助的癌症结果研究做好充分准备，并作为多学科研究团队的一部分有效地开展这项工作。

DESCRIPTION (provided by applicant): We request continued funding for the highly successful, Dana-Farber/Harvard Cancer Center (DF/HCC) Program in Cancer Outcomes Research Training (PCORT). PCORT is a unique, curriculum-based, inter-disciplinary program dedicated to the goal of training leaders in cancer outcomes and healthcare delivery research, with a particular focus on cancer prevention and control. We believe that PCORT has sufficient research and training opportunities to provide a comprehensive research training experience, and that our success - and the success of our trainees - justifies this request for continued funding. Funding will allow continued recruitment of 2 new M.D. and/or Ph.D. trainees and 1 new pre-doctoral trainee per year. Because all trainees spend a minimum of 2 years in the Program, we will maintain a total of 6 trainees in the Program at all times. We will recruit individuals wit diverse prior research experience and training, and will integrate all trainees into a highly collaborative research environment. We will also actively recruit highly qualified minority and women applicants to the program. The Program has 3 components: 1) a specialized curriculum; 2) active participation in other didactic experiences; and, 3) mentored, multidisciplinary cancer-related outcomes research. The specialized curriculum involves weekly seminars, including both didactic lectures and "research-in-progress" presentations by trainees and faculty. Appropriately qualified trainees also attend the Harvard Program in Clinical Effectiveness (PCE), a joint Program of Brigham and Women's Hospital, Massachusetts General Hospital, Harvard Medical School, and Harvard School of Public Health. The PCE is an intensive, seven-week, 15 credit classroom-based program that includes required courses in epidemiology and biostatistics, as well as a variety of electives. Trainees are encouraged to enroll in or may audit additional courses throughout the Harvard University system that are appropriate for their level of training. Virtuall all M.D. post-doctoral fellows complete a Masters Degree (M.P.H. or M.Sc.) at the Harvard School of Public Health. Trainees spend the largest part of their time participating in mentored cancer outcomes research under the supervision of PCORT mentors. Individual projects are developed by agreement among the trainee, his/her mentors and the PCORT Program Director, and approved by the PCORT Advisory Committee. All projects are multidisciplinary and highly collaborative. There is a strong emphasis on team science. Trainees are exposed to a broad range of cancer outcomes research methods and topics. Trainees are evaluated throughout and upon completion of the Program. After successful completion of the training program, they will be well prepared to conduct independent, externally funded, cancer outcomes research, and to do so effectively as part of a multidisciplinary research team.